Catherine Skari
-
Oct- 2021 -11 October
-
Jan- 2019 -3 January
-
Dec- 2018 -19 DecemberPress Releases
Sir David Weatherall, an ‘iconic’ scientist who carried out groundbreaking work in thalassaemia, dies
The international scientific and research community is mourning the loss of Sir David Weatherall, the highly-regarded British clinical scientist and…
Read More » -
Jul- 2022 -15 JulyNews
POLICY NEWS | TIF Issues Statement On The New EU Regulation For Blood, Tissues And Cells
This single Regulation, once approved by Member States, will replace all existing EU Directives on Blood, Tissues and Cells and…
Read More » -
Oct- 2021 -5 OctoberNews
Juggling Between The Cost And Value of New Therapies: Does Science Still Serve Patient Needs?
In the aftermath of the withdrawal of Zynteglo, the first gene therapy for patients with β-thalassaemia, from Europe, TIF´s Executive…
Read More » -
4 OctoberTIF News
Coming Up This Thursday: Discussion On Access To Innovative Therapies – The Reblozyl Case
After receiving numerous questions from patients regarding the innovative treatment for β-thalassaemia Reblozyl (luspatercept), approved for use in the US,…
Read More » -
2 OctoberNews
UK & Wales: NICE Recommends First Treatment In Two Decades For Sickle Cell Disease
For the first time in 20 years, a new therapy for sickle cell disease is to be made available on…
Read More » -
Sep- 2021 -22 September
-
22 September
-
22 September
